Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics.
Tortorici MA, Toh M, Rahavendran SV, Labadie RR, Alvey CW, Marbury T, Fuentes E, Green M, Ni G, Hee B, Pithavala YK.
Tortorici MA, et al. Among authors: toh m.
Invest New Drugs. 2011 Dec;29(6):1370-80. doi: 10.1007/s10637-010-9477-4. Epub 2010 Jul 2.
Invest New Drugs. 2011.
PMID: 20596748
Free PMC article.
Clinical Trial.